28 studies found for:    " December 30, 2007":" January 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Motivational interviewing with cognitive behavioral therapy;   Behavioral: Modified directly observed therapy
2 Completed
Has Results
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Conditions: Lipodystrophy;   HIV Infections
Interventions: Drug: Tesamorelin;   Drug: Placebo for Tesamorelin
3 Unknown  Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
Condition: HIV Infections
Interventions: Behavioral: HIV-related text messaging;   Behavioral: Nutrition-related text messaging
4 Completed Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)
Condition: HIV Infections
Intervention: Drug: Vicriviroc
5 Completed Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department
Condition: HIV Infections
Intervention: Other: Non-targeted opt-out rapid HIV screening
6 Completed Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Pegasys (ART Replacement Therapy)
7 Unknown  Pharmacotherapy for HIV+ Stimulant Dependent Individuals
Conditions: HIV Infections;   Cocaine Dependence
Intervention: Drug: ondansetron
8 Completed Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lopinavir / ritonavir;   Drug: Lopinavir/ritonavir
9 Completed HIV Non Occupational Post-Exposure Prophylaxis (PEP)
Condition: HIV Infections
Intervention: Drug: Fixed-dose Formulation of Tenofovir and Raletgravir
10 Completed HIV, Abuse, and Psychiatric Disorders Among Youth
Condition: HIV Infections
Intervention: Behavioral: group intervention
11 Completed
Has Results
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate;   Drug: Zidovudine;   Drug: Emtricitabine
12 Completed HIV and Hepatitis Care Coordination in Methadone Treatment
Conditions: Hepatitis, Viral, Human;   HIV Infections
Interventions: Behavioral: Testing, Education, & Counseling (TEC);   Behavioral: Hepatitis Care Coordination (HCC)
13 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
14 Completed Mindfulness Meditation Training in HIV
Condition: HIV Infections
Intervention: Behavioral: MBSR
15 Completed Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: Lamivudine (3TC)
16 Completed Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Tenofovir gel placebo
17 Completed Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir gel
18 Completed Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Conditions: HIV Infections;   Hepatitis C
Intervention: Drug: Peginterferon alfa-2a + ribavirin
19 Unknown  Stress-Reducing Interventions in HIV+ Patients: Pilot
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: Prolonged Exposure Therapy
20 Completed Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Condition: HIV Infections
Interventions: Drug: Darunavir 900mg + ritonavir 100 mg once a day;   Drug: Darunavir 600mg + ritonavir 100mg twice day

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years